The mechanism for the increased glycaemic response to sulfonylureas observed in HNF1A MODY, compared with Type 2 diabetes, is thought to be attributable to increased pancreatic insulin secretory response to sulfonylureas and increased sensitivity to the insulin released 1. The gene discussed is HNF1A; the disease is type 2 diabetes mellitus.